Publications
Blood tolerogenic monocytes and low proportions of dendritic cell subpopulations are hallmarks of human tuberculosis Vrije Universiteit Brussel
BACKGROUND: The immune mechanisms underlying the pathogenesis of tuberculosis (TB) need better understanding to improve TB management, as the disease still causes more than 1.5 million deaths annually. This study tested the hypothesis that a modulation of the proportions or activation status of APC during Mycobacterium tuberculosis infection may impact on the course of the disease.
PROCEDURE: Proportions of circulating APC subsets and ...
The long lifespan and how turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Vrije Universiteit Brussel
pathogenesis of type 2 diabetes by genetic markers for diabetes. Decreased beta
cell neogenesis could contribute to diabetes. The longevity and turnover of human
beta cells is unknown; in rodents estimated. Intracellular lipofuscin body (LB) accumulation is a hallmark of
ageing in neurons. To estimate the lifespan ...
High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa University of Antwerp
From non school-based, co-payment to school-based, free Human Papillomavirus vaccination in Flanders (Belgium): A retrospective cohort study describing vaccination coverage, age-specific coverage and socio-economic inequalities Hasselt University KU Leuven
From non school-based, co-payment to school-based, free Human Papillomavirus vaccination in Flanders (Belgium) University of Antwerp
Limited weight impact after switching from boosted protease ihibitors to dolutegravir in persons with human immunodeficiency virus with high cardiovascular risk: a post hoc analysis of the 96-week NEAT-022 randomized trial Institute of Tropical Medicine
Background
In the NEAT022 trial, virologically suppressed persons with human immunodeficiency virus (HIV) at high cardiovascular risk switching from protease inhibitors to dolutegravir either immediately (DTG-I) or after 48 weeks (DTG-D) showed noninferior virological suppression and significant lipid and cardiovascular disease risk reductions on switching to dolutegravir relative to continuing protease inhibitors.
Methods ...